Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact

por Esquenazi, Alberto, Jost, Wolfgang H., Turkel, Catherine C., Wein, Theodore, Dimitrova, Rozalina
Publicado 2023

Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact

por Turkel, Catherine C., Aurora, Sheena, Diener, Hans-Christoph, Dodick, David W., Lipton, Richard B., Silberstein, Stephen D., Brin, Mitchell F.
Publicado 2023

Depression and risk of transformation of episodic to chronic migraine

por Ashina, Sait, Serrano, Daniel, Lipton, Richard B., Maizels, Morris, Manack, Aubrey N., Turkel, Catherine C., Reed, Michael L., Buse, Dawn C.
Publicado 2012

Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT

por Silberstein, Stephen D, Dodick, David W, Aurora, Sheena K, Diener, Hans-Christoph, DeGryse, Ronald E, Lipton, Richard B, Turkel, Catherine C
Publicado 2015